These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 34476218)

  • 1. Vascular Normalization: A New Window Opened for Cancer Therapies.
    Yang T; Xiao H; Liu X; Wang Z; Zhang Q; Wei N; Guo X
    Front Oncol; 2021; 11():719836. PubMed ID: 34476218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular normalization in immunotherapy: A promising mechanisms combined with radiotherapy.
    Liu Z; Zhao Q; Zheng Z; Liu S; Meng L; Dong L; Jiang X
    Biomed Pharmacother; 2021 Jul; 139():111607. PubMed ID: 33965730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular-immuno-phenotypic (VIP) model for locally advanced and oligo-metastatic cancer: A hypothesis.
    Swamy K
    Med Hypotheses; 2021 Jul; 152():110618. PubMed ID: 34102599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apelin as a marker for monitoring the tumor vessel normalization window during antiangiogenic therapy.
    Zhang L; Takara K; Yamakawa D; Kidoya H; Takakura N
    Cancer Sci; 2016 Jan; 107(1):36-44. PubMed ID: 26475217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity.
    Panagi M; Voutouri C; Mpekris F; Papageorgis P; Martin MR; Martin JD; Demetriou P; Pierides C; Polydorou C; Stylianou A; Louca M; Koumas L; Costeas P; Kataoka K; Cabral H; Stylianopoulos T
    Theranostics; 2020; 10(4):1910-1922. PubMed ID: 32042344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vessel pruning or healing: endothelial metabolism as a novel target?
    Cantelmo AR; Pircher A; Kalucka J; Carmeliet P
    Expert Opin Ther Targets; 2017 Mar; 21(3):239-247. PubMed ID: 28081641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.
    Fukumura D; Kloepper J; Amoozgar Z; Duda DG; Jain RK
    Nat Rev Clin Oncol; 2018 May; 15(5):325-340. PubMed ID: 29508855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic therapy reverses the immunosuppressive breast cancer microenvironment.
    Chen W; Shen L; Jiang J; Zhang L; Zhang Z; Pan J; Ni C; Chen Z
    Biomark Res; 2021 Jul; 9(1):59. PubMed ID: 34294146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune consequences of tyrosine kinase inhibitors that synergize with cancer immunotherapy.
    Kwilas AR; Donahue RN; Tsang KY; Hodge JW
    Cancer Cell Microenviron; 2015; 2(1):. PubMed ID: 26005708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting tumor vascularization: promising strategies for vascular normalization.
    Zheng R; Li F; Li F; Gong A
    J Cancer Res Clin Oncol; 2021 Sep; 147(9):2489-2505. PubMed ID: 34148156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Vasculatures: A New Target for Cancer Immunotherapy.
    Liu Z; Wang Y; Huang Y; Kim BYS; Shan H; Wu D; Jiang W
    Trends Pharmacol Sci; 2019 Sep; 40(9):613-623. PubMed ID: 31331639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model.
    Jain RK; Tong RT; Munn LL
    Cancer Res; 2007 Mar; 67(6):2729-35. PubMed ID: 17363594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bifunctional Therapeutic Peptide Assembled Nanoparticles Exerting Improved Activities of Tumor Vessel Normalization and Immune Checkpoint Inhibition.
    Taleb M; Atabakhshi-Kashi M; Wang Y; Rezvani Alanagh H; Farhadi Sabet Z; Li F; Cheng K; Li C; Qi Y; Nie G; Ying Z
    Adv Healthc Mater; 2021 Jun; 10(12):e2100051. PubMed ID: 34021735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic therapy: Markers of response, "normalization" and resistance.
    El Alaoui-Lasmaili K; Faivre B
    Crit Rev Oncol Hematol; 2018 Aug; 128():118-129. PubMed ID: 29958627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity.
    Leuci V; Maione F; Rotolo R; Giraudo E; Sassi F; Migliardi G; Todorovic M; Gammaitoni L; Mesiano G; Giraudo L; Luraghi P; Leone F; Bussolino F; Grignani G; Aglietta M; Trusolino L; Bertotti A; Sangiolo D
    J Transl Med; 2016 May; 14(1):119. PubMed ID: 27149858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental study of the vascular normalization window for tumors treated with apatinib and the efficacy of sequential chemotherapy with apatinib in lung cancer-bearing mice and patients.
    Liu M; Li H; Wang X; Jing L; Jiang P; Li Y
    Cancer Med; 2020 Apr; 9(8):2660-2673. PubMed ID: 32073228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation in combination with antiangiogenesis and chemotherapy for cancer patients: evidence and hypothesis.
    Wang J; Zhu C
    Onco Targets Ther; 2016; 9():4737-46. PubMed ID: 27536135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination antiangiogenic therapy and radiation in head and neck cancers.
    Hsu HW; Wall NR; Hsueh CT; Kim S; Ferris RL; Chen CS; Mirshahidi S
    Oral Oncol; 2014 Jan; 50(1):19-26. PubMed ID: 24269532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor vessel normalization after aerobic exercise enhances chemotherapeutic efficacy.
    Schadler KL; Thomas NJ; Galie PA; Bhang DH; Roby KC; Addai P; Till JE; Sturgeon K; Zaslavsky A; Chen CS; Ryeom S
    Oncotarget; 2016 Oct; 7(40):65429-65440. PubMed ID: 27589843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulation of immune‒vascular crosstalk: new strategies towards cancer treatment.
    Zhao Y; Yu X; Li J
    Acta Pharm Sin B; 2020 Nov; 10(11):2018-2036. PubMed ID: 33304777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.